Last reviewed: June 29, 2026 Last updated: June 29, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
The FDA relationship with compounding pharmacies, particularly those filling GLP-1 prescriptions, has become increasingly contentious
Primary Handling Editor: Karen OLeary, in collaboration with the Nature Medicine team
Products from different brands or stores can be combined into one shipment when shipped from the same origin country
months According to research from the University of Cambridge, patients may regain up to three-quarters of the weight semaglutide helped them lose